title: Endothelin in chronic renal failure.
abstract: The aims of the present study were to determine plasma endothelin (ET) in chronically uraemic patients, the renal clearance of endogenous ET in normal dog and man, and the effect of acute volaemic expansion on ET. The mean plasma ET concentration in haemodialysis patients was 57.5 +/- 5 pg/ml before haemodialysis and remained unchanged at 52.5 +/- 5 pg/ml after haemodialysis. They were thus significantly elevated both before and after haemodialysis (P less than 0.01) compared with plasma ET in normal subjects of 20.8 +/- 0.8 pg/ml. There was no evidence of ET clearance across the cuprophane membrane of the dialyser. Resting plasma ET values in the 15 non-dialysed uraemic patients ranged between 20 and 52.5 pg/ml (mean 38.2 +/- 2.3 pg/ml), significantly greater than those observed in controls (P less than 0.01). In CAPD patients, plasma ET was also significantly (P less than 0.01), elevated (63 +/- 10 pg/ml) when compared to controls, and similar to those observed in patients before haemodialysis. In dogs, mean ET did not diminish between the aorta and the renal vein (28.1 +/- 1 versus 28.4 +/- 2 pg/ml). In man mean ET did not significantly decline between the renal artery and the renal vein (17 +/- 3 to 13 +/- 0.8 pg/ml). In the seven healthy subjects who received 2000 ml of isotonic saline intravenously ET remained unchanged (24 +/- 2; 23 +/- 1 and 23 +/- 2 pg/ml before and 1 and 2 h after starting hydration respectively). We have thus shown that plasma ET is elevated in patients with chronic renal failure especially those on dialysis and CAPD.(ABSTRACT TRUNCATED AT 250 WORDS)
authors.affiliation: Department of Nephrology, Hospital Pitie-Salpetriere, Paris, France.
authors.forename: G
authors.initials: G
authors.lastname: Deray
authors.forename: A
authors.initials: A
authors.lastname: Carayon
authors.forename: G
authors.initials: G
authors.lastname: Maistre
authors.forename: M
authors.initials: M
authors.lastname: Benhmida
authors.forename: F
authors.initials: F
authors.lastname: Masson
authors.forename: C
authors.initials: C
authors.lastname: Barthelemy
authors.forename: T
authors.initials: T
authors.lastname: Petitclerc
authors.forename: C
authors.initials: C
authors.lastname: Jacobs
mesh_terms: D000818:Animals; D001810:Blood Volume; D004285:Dogs; D016232:Endothelins / Q000097:blood*; D005260:Female; D006801:Humans; D007552:Isotonic Solutions; D007676:Kidney Failure, Chronic / Q000097:blood* / Q000628:therapy; D008297:Male; D008875:Middle Aged; D010531:Peritoneal Dialysis, Continuous Ambulatory; D006435:Renal Dialysis; D012965:Sodium Chloride / Q000008:administration & dosage; D014511:Uremia / Q000097:blood / Q000628:therapy
chemical_list: D016232:Endothelins; D007552:Isotonic Solutions; D012965:Sodium Chloride